M
Metabiota
Delivering actionable, data-driven insights that help organizations manage infectious disease risk
About Metabiota
Metabiota is a San Francisco-based company with over a decade of experience in helping industries and governments worldwide prepare for and manage epidemic risks. With additional offices in Washington DC, Cameroon, and the Democratic Republic of the Congo, Metabiota operates on a global scale. The company specializes in providing data, analytics, advice, and training to support decision-makers in making informed, data-driven choices to protect public health and ensure global health security.
Read full description
Metabiota serves a diverse range of clients, including corporate entities, insurance companies, government agencies, and multilateral organizations. The company operates in the public health and epidemic risk management market, focusing on estimating, mitigating, and managing the risks associated with epidemics. This is crucial as epidemics can have devastating impacts on both lives and economies.
The business model of Metabiota revolves around offering a suite of services that include data collection and analysis, risk assessment, and strategic advisory. They also provide training programs to help organizations build resilience against potential health threats. By leveraging their expertise in various scientific disciplines such as epidemiology, veterinary medicine, laboratory science, data science, actuarial science, social science, and political economics, Metabiota delivers comprehensive solutions to its clients.
Metabiota generates revenue through the sale of its data and analytics services, consulting fees, and training programs. The company has been recognized for its innovative solutions, winning several awards such as Catastrophe Risk Modelling Solution of the Year 2020 and Insurtech Impact 25 in 2019.
In summary, Metabiota is a key player in the field of epidemic risk management, providing essential tools and insights to help organizations worldwide prepare for and mitigate the impacts of global health threats.
At a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- San Francisco, United States
- Employees
- 83
- Open positions
- None listed
- Dealroom signal
- 58.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Supply Chain Management, Risk Management, Analytics, Biotechnology, Biotech and Pharma, Parametric Insurance, Hard Tech, DT and LS, science-based
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Jun 2016
- Capital deployed
- $8.9M
- Preferred round
- SERIES A
Latest news
Press, funding announcements and product moves mentioning Metabiota.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jun 2026 | $0 | — | Undisclosed | ↗ |
| SERIES BEquity / VC | Dec 2018 | $0 | — | In-Q-Tel | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Metabiota is 1.5K monthly website visits, down 50% over the last three months. Metabiota's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
AnceraBranford, United StatesFood supply chain intelligence mitigating microbial risks
$36Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed10 investors entered at this stage
Pilot Growth Equity- TOTim O'Reilly
DCVC
Georges Harik
Tao Capital Partners
Stephen Luczo
Adrian Aoun
Undercurrent
James Joaquin
SciFi VC
Series A9 investors entered at this stage
Capricorn Investment Group
Industry Ventures
Zachary Bogue
Obvious Ventures
WP Global
SharesPost- SLSteven Luczo
Martis Capital
In-Q-Tel
Other known investors3 additional known investors
GV
Lloyd's lab
Technology Pioneers | World Economic Forum
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Metabiota on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Metabiota’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







